HOME >> MEDICINE >> NEWS
Anesthesia duration not an indicator of adverse outcomes for patients having plastic surgery

The length of time patients spend under anesthesia during outpatient facial plastic surgery procedures does not appear to be linked to their risk of injury or death, according to a study in the January issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.

Several high-profile patient deaths in office-based plastic surgery facilities have led state regulatory agencies and medical boards to develop policies regarding the procedures performed at these locations, according to background information in the article. Some, including those in Pennsylvania and Tennessee, have mandated that any surgeries longer than four hours (240 minutes) be performed in an inpatient facility. However, there is little data on which regulatory bodies can base these types of decisions, the authors write. "Defining the risks and morbidity related to longer procedure duration, specifically in facial plastic surgery, has great significance because of the necessity to treat the aging face as a unit, thus appropriately combining multiple procedures" that will require longer surgeries, they report.

Neil A. Gordon, M.D., Yale University School of Medicine, New Haven, Conn., and Marc E. Koch, M.D., State University of New York at Stony Brook, evaluated 1,200 patients who had undergone facial plastic surgery between July 1995 and February 2005. Of those, 1,032 (86 percent) were under anesthesia for more than 240 minutes. Most of the patients in the longer anesthesia group underwent multiple facial procedures, while most in the shorter anesthesia group had only rhinoplasty (plastic surgery on the nose). All of the procedures were performed by a board-certified surgeon; 1,008 of them were performed by Dr. Gordon, accompanied by board-certified anesthesiologists.

Each participant was monitored the day after the surgery. No deaths were reported in the study and the rate of complications was similar in both groups. Three patients overall--one in the
'"/>

Contact: Jacqueline Weaver
203-432-8555
JAMA and Archives Journals
16-Jan-2006


Page: 1 2

Related medicine news :

1. Extended duration work shifts risky to the safety, well-being of medical interns, patients
2. Breastfeeding duration rates for infants born in an inner-city WHO/UNICEF Baby-Friendly hospital
3. Doctors extended duration work shifts are associated with medical errors and adverse events
4. HAQ responsiveness is inversely associated with mean duration of RA in clinical trials
5. Type of stress, not duration, key to heart enlargement
6. First long-duration mission for an ESA astronaut onboard the ISS
7. Complications in plastic surgery are unrelated to duration of anesthesia
8. Increased duration of breastfeeding associated with decreased risk of diabetes
9. Lower mortality rates associated with hospitals that rank highest on quality of care indicators
10. Position of car indicator lights affects safety -- designers should take note
11. Listen to your heart: Researchers discover a physiological indicator of vulnerability to temptation

Post Your Comments:
(Date:8/1/2014)... New York (PRWEB) August 01, 2014 ... in the wake of the 2012 Rejuvenate and ... move forward in New Jersey’s Bergen County Superior ... filed in the proceeding, the Court has ... Confidentiality governing any and all hard copy and ...
(Date:8/1/2014)... Summer is here, and with it comes the ... and they can be a pain for dogs. Animal Emergency ... their customers get rid of ticks and prevent them completely. ... the summer, which is why they are so active during ... woodland areas and carry a number of diseases, including lyme ...
(Date:8/1/2014)... The American Telemedicine Association (ATA) lauds ... Peter Welch (D-VT), for their latest actions to ... of 2014, which improves telemedicine coverage in Medicare. ... healthcare access and affordability using telecommunications technology," said ... cost-saving provisions are critical to improve telehealth coverage ...
(Date:8/1/2014)... 2014 The "Antimicrobial Coatings Market ... Zinc Oxide, Titanium Dioxide, and Zinc Omadine), Application ... Food & Beverages, Textiles, and others), & Geography ... Trends and Forecasts to 2018" analyzes the Antimicrobial ... and trends in the diverse geographical regions. , ...
(Date:8/1/2014)... August 01, 2014 The North America ... security solutions market in North America with analysis and ... from around $3.53 billion in 2014 to $4.77 billion ... to 2019. , Browse through the TOC of the ... idea of the in-depth analysis provided. It also provides ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:Tis the Season for Tick Prevention 2Health News:ATA Applauds Bill on Medicare Telemedicine Improvements 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 4
(Date:7/31/2014)... SAN DIEGO, July 31, 2014  ResMed Inc. (NYSE: ... and for the fiscal year ended June 30, 2014.  Revenue ... quarter ended June 30, 2013 (a 1 percent decrease on ... increase of 20 percent compared to the quarter ended June ... $0.61, an increase of 22 percent compared to the quarter ...
(Date:7/31/2014)... FRANCISCO, July 31, 2014 Nektar Therapeutics (Nasdaq: ... second quarter ended June 30, 2014. Cash ... $301.4 million as compared to $309.1 million at March 31, ... for Nektar as we look forward to significant milestones for ... Robin, President and Chief Executive Officer of Nektar. "The first ...
(Date:7/31/2014)... Mass. , July 31, 2014 /PRNewswire/ ... funding changes brought about by the Affordable ... reimbursement and prescribing of pharmaceutical therapies. The ... cover beneficiaries through new regulations and expanded ... occurring in the health exchanges—state-based marketplaces set ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4
Cached News: